Carmelo Lafuente-Lafuente

Summary

Publications

  1. ncbi Long term treatment of atrial fibrillation in elderly patients: a decision analysis
    Carmelo Lafuente-Lafuente
    Service de Medecine A, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, Université Paris Cité Diderot, Paris, France
    Int J Cardiol 155:102-9. 2012
  2. ncbi Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
    Carmelo Lafuente-Lafuente
    Service deGériatrie à orientation Cardiologique etNeurologique, Groupe hospitalier Pitié Salpêtrière Charles Foix, AP HP, UniversitéPierre et Marie Curie Paris 6, Ivry sur Seine, France
    Cochrane Database Syst Rev 5:CD005049. 2012
  3. ncbi Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials
    Carmelo Lafuente-Lafuente
    Service de Medecine Interne A, Hopital Lariboisiere, Paris, France
    Arch Intern Med 166:719-28. 2006
  4. ncbi Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity
    Carmelo Lafuente-Lafuente
    AP HP, Hopital Lariboisiere, Department of Internal Medicine A, Paris, France
    Br J Clin Pharmacol 67:511-9. 2009

Detail Information

Publications4

  1. ncbi Long term treatment of atrial fibrillation in elderly patients: a decision analysis
    Carmelo Lafuente-Lafuente
    Service de Medecine A, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, Université Paris Cité Diderot, Paris, France
    Int J Cardiol 155:102-9. 2012
    ..Atrial fibrillation (AF) is more frequent with age but it is not clear whether, and how, older age should influence therapeutic choice...
  2. ncbi Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
    Carmelo Lafuente-Lafuente
    Service deGériatrie à orientation Cardiologique etNeurologique, Groupe hospitalier Pitié Salpêtrière Charles Foix, AP HP, UniversitéPierre et Marie Curie Paris 6, Ivry sur Seine, France
    Cochrane Database Syst Rev 5:CD005049. 2012
    ..AF recurs frequently after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent recurrence, but the effect of these drugs on mortality and other clinical outcomes is unclear...
  3. ncbi Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials
    Carmelo Lafuente-Lafuente
    Service de Medecine Interne A, Hopital Lariboisiere, Paris, France
    Arch Intern Med 166:719-28. 2006
    ..We performed a systematic review to determine the effect of long-term treatment with those drugs on death, embolisms, adverse effects, and atrial fibrillation recurrence...
  4. ncbi Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity
    Carmelo Lafuente-Lafuente
    AP HP, Hopital Lariboisiere, Department of Internal Medicine A, Paris, France
    Br J Clin Pharmacol 67:511-9. 2009
    ..To determine if amiodarone, highly lipophilic, accumulates in excess with respect to dose in fat tissue during long-term administration, and study if plasma and fat tissue concentrations are correlated with adverse effects...